A detailed history of Smartleaf Asset Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 311 shares of TGTX stock, worth $10,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares
311
Previous 248 25.4%
Holding current value
$10,906
Previous $4.45 Million 66.5%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$17.21 - $25.28 $1,084 - $1,592
63 Added 25.4%
311 $7.41 Million
Q2 2024

Aug 13, 2024

BUY
$13.32 - $19.19 $2,863 - $4,125
215 Added 651.52%
248 $4.45 Million
Q1 2024

Oct 07, 2024

SELL
$13.02 - $21.3 $2,799 - $4,579
-215 Reduced 86.69%
33 $513,000
Q1 2024

May 02, 2024

BUY
$13.02 - $21.3 $429 - $702
33 New
33 $581,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.09B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.